Siemens Aktiengesellschaft · XETR:SIE
Siemens Aktiengesellschaft — Siemens — Investor Day (December 2014)
13 slides from Siemens Aktiengesellschaft's investor day presentation, Dec 9, 2014
Slide 1: Healthcare – Solid performance, strong perspectives
Hermann Requardt | Member of the Managing Board & Healthcare CEO Healthcare – Solid performance, strong perspectives Siemens Capital Market Day | Berlin, December 9, 2014 © Siemens AG 2014
Slide 2: Notes and forward-looking statements
Notes and forward-looking statements This document contains statements related to our future business and financial performance and future events or developments involving Siemens that may constitute forward-looking statements. These statements may be identified by words such as “expect,” “look forw
Slide 3: Healthcare key figures FY 2014
Healthcare key figures FY 2014 Orders Revenue in €bn in €bn +2%1) +2%1) 12.3 (-2%) 12.1 12.0 (-2%) 11.7 FY 2013 FY 2014 FY 2013 FY 2014 Profit and margin Free Cash Flow in €bn in €bn 18.7% 17.1% -160 bps -9% 2.2 2.0 2.1 1.9 2.1 2.0 17.7% 17.7% FY 2013 FY 2014 FY 2013 FY 2014 x.x% Profit margin x.x%
Slide 4: Diagnostics key figures FY 2014
Diagnostics key figures FY 2014 Revenue Profit and margin in €bn in €m +1%1) 3.9 (-3%) 3.8 15.0% 15.1% +10 bps 590 579 519 13.2% FY 2013 FY 2014 FY 2013 FY 2014 x.x% Profit margin x.x% Underlying profit margin2) Note: Growth rates in brackets as reported; 1) Comparable, i.e. adjusted for currency tr
Slide 5: Delivering continuously attractive margins
Delivering continuously attractive margins Healthcare profitability Agenda 2013 18.4% 18.7% Underlying 17.3% 17.0% 17.1% profit 16.1% Total HC margin1) 17.6% HC DX (in %) 15.6% 15.1% 15.0% 14.1% 13.2% Underlying 2.2 2.0 1.9 2.0 2.0 Total HC profit1) 1.6 (in €bn) 0.6 0.6 0.5 0.6 0.6 0.6 HC DX FY 2009
Slide 6: China and Japan: Our biggest growth drivers
China and Japan Our biggest growth drivers Equipment orders Growth2) in €m FY 2009 FY 2014 CAGR FY 2009-2014 #1 U.S. 24%1) #1 U.S. 26%1) U.S. +3% #2 Germany 8%1) #2 China 14%1) China +15% #3 China 8%1) #3 Japan 9%1) Japan +7% #4 Japan 6%1) #4 Germany 7%1) Germany -3% 1) In % of total equipment order
Slide 7: Acting in transitioning healthcare markets
Acting in transitioning healthcare markets Focus on cost contain- Government pushes Health expenditures al- ment and clinical value for expansion of rural healthcare most doubled in the past 20 years Number of Accountable Installed imaging in trYen 39 ~50k ~80k 37 Care Organizations units in county
Slide 8: Expanding our footprint in growth fields based on core technologies
Expanding our footprint in growth fields based on core technologies Growing into therapy Accessing new Serving global related markets patient populations entry-level markets • World market leader for hybrid • Develop new applications • Leading technology to further ORs in an attractive market that i
Slide 9: Providing platforms to improve operational efficiency and clinical quality
Providing platforms to improve operational efficiency and clinical quality Service platforms leveraging the installed base Remote services • Proactive system monitoring and repair • Performance plans/ Scalable DX platforms for Software platforms to raise uptime services all customer segments diagnos
Slide 10: Trends leading to a paradigm shift?
Trends leading to a paradigm shift? Potentially dis- Structures in transition ruptive advances • Industrialization of healthcare • Molecular diagnostics, life • Value-based reimbursement science tools, next generation • Convergence of diagnostics sequencing and therapy • Big data analytics/Next-Gen
Slide 11: With Agenda 2013, Healthcare initiated clean-up and invest
With Agenda 2013, Healthcare initiated clean-up and invest to adjust to changing market environment Investment Adjustment Respond to paradigm shifts in healthcare PT1) Organic and in-organic LINAC investment/innovation in new growth opportunities Entry-level systems Portfolio Therapy systems streaml
Slide 12: Healthcare of Tomorrow (HoT) with enhanced process autonomy and strategic flexibility
Healthcare of Tomorrow (HoT) with enhanced process autonomy and strategic flexibility Dedicated regulatory Ensuring market access in a strictly regulated environment for and release processes Siemens Healthcare, communication with regulatory bodies and governmental institutions Domain-specific IT Ta
Slide 13: Proactively shaping our present and future
Proactively shaping our present and future Healthcare with a continued strong performance in changing market environments After implementing Agenda 2013 measures, Healthcare is getting ready to attack new fields – centered around outcome relevant medical decisions Separately managed “company within